med spa los angeles semaglutide Weight Loss Treatment Near Me in Los Angeles - GLP-1 Semaglutide

I have so much more energy

Announced by Novo Nordisk on May 2, 2025, the investigational oral formulation of semaglutide is targeted for chronic weight management in patients with obesity or overweight and 1 comorbid condition and to reduce the risk of major adverse cardiovascular events (MACE) in those with overweight or obesity and established cardiovascular disease

This program is best for certain people

The idea is to use the lowest effective dose to prevent regain without the side effects associated with higher therapeutic doses

Results, particularly any cosmetic ones, build gradually with consistency and vary quite a lot from person to person